Welcome - Register - Login - Help/FAQ - 0 items

Search Enter keywords, a title or a report id number below. In All Categories --------------------- Telecom & Computing Business & Finance Mfg & Construction Pharma & Healthcare Consumer & Retail Gov & Public Sector Energy & Transport Country Reports Company Reports --------------------- Transcripts Advanced      Select a currency for use throughout the site Australia Dollars Canada Dollars Euro Japan Yen Sweden Kroner Switzerland Francs UK Pounds US Dollars Search Results Your Search for 'Cystic Fibrosis' returned 269 results - Page 1 of 14   Sort by    Date Published ASC Date Published DESC Report Price ASC Report Price DESC Rank ASC Rank DESC   Sorted by Rank Top-Bottom Cystic Fibrosis   Informa Healthcare, March 2010, Pages: 1044 The median age of survival for those with cystic fibrosis has risen considerably in recent years. This text thoroughly examines the developments and breakthroughs which have led to this improvement Cystic Fibrosis - Global Strategic Business Report   Global Industry Analysts, Inc., June 2010, Pages: 402 This report analyzes the US market for Cystic Fibrosis in Millions of US$. Annual estimates and forecasts are provided for the period of 2007 through 2015. Also, a six-year historic analysis Will the Approval of New Agents Redefine the Cystic Fibrosis Market?   Decision Resources, Inc., April 2011, Pages: 38 The cystic fibrosis (CF) pipeline includes agents that target not only the symptoms of the disease but also the main cause of the disease - defective chloride transport. Interviewed key opinion Global Cystic Fibrosis Drug Pipeline Capsule - 2011   Fore Pharma, Aug 2011, Pages: 13 Fore Pharma’s latest report ‘Global Cystic Fibrosis Drug Pipeline Capsule – 2011’ is an outline of all the key research and development (R&D) activities of the global cystic fibrosis drug Cystic Fibrosis - Pipeline Assessment and Market Forecasts to 2017   GlobalData, Aug 2010, Pages: 49 Cystic Fibrosis - Pipeline Assessment and Market Forecasts to 2017 Summary Our pharmaceutical and healthcare report, “Cystic Fibrosis - Pipeline Assessment and Market Forecasts to 2017 Global Cystic Fibrosis Drug Pipeline Capsule - 2012   Fore Pharma, Jan 2012, Pages: 13 Fore Pharma’s latest report ‘Global Cystic Fibrosis Drug Pipeline Capsule – 2012’ is an outline of all the key research and development (R&D) activities of the global cystic fibrosis drug Cystic Fibrosis: Will New Agents Emerge as First-Line Therapies?   Decision Resources, Inc., June 2008, Pages: 39 The cystic fibrosis (CF) market is poised for significant change. The next generation of CF treatments all target the central mechanism responsible for organ damage in CF. These agents, as one Cystic Fibrosis (CF) Therapeutics - Pipeline Assessment and Market Forecasts to 2018   GlobalData, Sep 2011, Pages: 83 Cystic Fibrosis (CF) Therapeutics - Pipeline Assessment and Market Forecasts to 2018 Summary GlobalData, the industry analysis specialist, has released its new report, “Cystic Fibrosis (CF Cystic Fibrosis Therapy Area Pipeline Report   Life Science Analytics, March 2011, Pages: 201 Cystic Fibrosis Therapy Area Pipeline Report contains detailed information on the cystic fibrosis drug pipeline. This report provides insight into the pipeline status of cystic fibrosis drugs Respiratory and Pulmonary System Cystic Fibrosis   Life Science Analytics, March 2008, Pages: 62 "Respiratory and Pulmonary System Cystic Fibrosis " contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of allergy drugs by company R&D Trends: Cystic Fibrosis - New drugs tackle both cause and effect   Datamonitor, Oct 2011, Pages: 68 Two decades after the identification of the cystic fibrosis transmembrane conductance regulator protein, approved drugs capable of correcting dysfunctions in this protein are nearing reality Cystic Fibrosis Global Clinical Trials Review, Q2, 2011   GlobalData, June 2011, Pages: 74 Cystic Fibrosis Global Clinical Trials Review, Q2, 2011 Summary GlobalData's clinical trial report, “Cystic Fibrosis Global Clinical Trials Review, Q1, 2011" provides data on the Cystic Fibrosis Cystic Fibrosis - Pipeline Review, Q4 2010   Global Markets Direct, Dec 2010, Pages: 81 Cystic Fibrosis - Pipeline Review, Q4 2010 Summary Global Markets Direct’s, “Cystic Fibrosis Pipeline Review, Q4 2010”, provides an overview of the Cystic Fibrosis therapeutic pipeline Cystic Fibrosis - Pipeline Review, H2 2011   Global Markets Direct, Sep 2011, Pages: 174 Cystic Fibrosis - Pipeline Review, H2 2011 Summary Global Markets Direct’s, 'Cystic Fibrosis - Pipeline Review, H2 2011', provides an overview of the Cystic Fibrosis therapeutic pipeline Cystic Fibrosis - Pipeline Review, Q1 2011   Global Markets Direct, Feb 2011, Pages: 84 Cystic Fibrosis - Pipeline Review, Q1 2011 Summary Global Markets Direct’s, 'Cystic Fibrosis - Pipeline Review, Q1 2011', provides an overview of the Cystic Fibrosis therapeutic pipeline Cystic Fibrosis Global Clinical Trials Review, Q4, 2010   GlobalData, Dec 2010, Pages: 73 Cystic Fibrosis Global Clinical Trials Review, Q4, 2010 Summary Our clinical trial report, “Cystic fibrosis Global Clinical Trials Review, Q4, 2010" provides data on the Cystic fibrosis clinical The 2011 Report on Cystic Fibrosis Drugs: World Market Segmentation by City   ICON Group International, Jan 2011, Pages: 329 Market Potential Estimation Methodology Overview This study covers the world outlook for Cystic Fibrosis drugs across more than 2000 cities. For the year reported, estimates are given for the latent The 2011-2016 World Outlook for Cystic Fibrosis Drugs   ICON Group International, Jan 2011, Pages: 194 smaller than the P.I.E. of levels at lower levels of the same value chain, assuming all levels maintain minimum profitability). The latent demand for Cystic Fibrosis drugs is not actual or historic sales Vertex's VX770 Is Poised To Become The First Targeted Therapy To Be Approved In Cystic Fibrosis   GlobalData, March 2011, Pages: 4 Vertex’s VX770 Is Poised To Become The First Targeted Therapy To Be Approved In Cystic Fibrosis Summary Our report, “Vertex’s VX770 Is Poised To Become The First Targeted Therapy To Be Approved Respiratory and Pulmonary System - Cystic Fibrosis Drug Pipeline Report   Life Science Analytics, June 2007, Pages: 11 Life Science Analytics, "Respiratory and Pulmonary System - Cystic Fibrosis Drug Pipeline Report" contains detailed information on the current drug pipeline. This report provides insight Results:  First -   Prev -   1 -   2 -   3 -   4 -   5 -   6 -   Next -   Last

		For enquiries please call us on:   +353-1-415-1241 (GMT Office Hours)   1-800-526-8630 (US/Canada Toll Free)   1-917-300-0470 (EST Office Hours)

All rights reserved. © Copyright 2012 Research and Markets1    Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network